Publication | Open Access

Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity

VaccinationCross-protectionNew Second-generation VirgVaccine DevelopmentVaccine TargetPathogenesisImmunologyVirologyReduced ReactogenicityInfection ControlPolyvalent VaccineVaccine DesignMedicineVaccine Research